MoneyWorks4Me

Piramal Pharma informs about analyst meet

04 Jun 2024 Evaluate
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Piramal Pharma has informed that pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the schedule of Analyst or Institutional Investor Meetings with the Company as on 18th June, 2024.

The above information is a part of company’s filings submitted to BSE.
Peers
Company Name CMP
Sun Pharma. Inds. 1845.40
Dr. Reddys Labs. 1219.20
Cipla 1386.20
Lupin 2058.40
Zydus Lifesciences 1209.10
View more..